Characterisation of the binding of [3H]methyllycaconitine: A new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors

Neuropharmacology

Volumn 38, Issue 5, 1999, Pages 679-690

  Davies, Andrew R L ^a   Hardick, David J ^a   Blagbrough, Ian S ^a   Potter, Barry V L ^a   Wolstenholme, Adrian J ^a   Wonnacott, Susan ^a  

^a University of Bath   (United Kingdom)

Author keywords

bungarotoxin; Acetylcholine receptor; Methyllycaconitine; Neuronal nicotinic

Indexed keywords

ALKALOID; ALPHA BUNGAROTOXIN; ANATOXIN A; COBROTOXIN; EPIBATIDINE; METHYLCARBACHOL; METHYLLYCACONITINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; ACONITINE; BUNGAROTOXIN; CHOLINERGIC RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; NICOTINE; NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA4 SUBUNIT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BINDING SITE; BRAIN MEMBRANE; BRAIN REGION; DRUG RECEPTOR BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SKELETAL MUSCLE; XENOPUS; ANIMAL; BINDING COMPETITION; BRAIN; CELL MEMBRANE; DRUG ANTAGONISM; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACONITINE; ANIMALS; BINDING, COMPETITIVE; BRAIN; BUNGAROTOXINS; CELL MEMBRANE; CHOLINERGIC AGENTS; MALE; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0032586785     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00221-4     Document Type: Article

References (55)

1. Alkondon M., Pereira E.F.R., Wonnacott S., Albuquerque E.X. Blockade of nicotinic currents in hippocampal-neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol. Pharmacol. 41:1992;802-808.
2. Alkondon M., Pereira E.F.R., Cortes W.S., Maelicke A., Albuquerque E.X. Choline is a selective agonist of α7 nicotinic acetylcholine receptors in the rat brain neurons. Eur. J. Neurosci. 9:1997;2734-2742.
3. Anand R., Peng X., Lindstrom J. Homomeric and native α7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEBS Lett. 327:1993;241-246.
4. Badio B., Daly J.W. Epibatidine, a potent analgesic and nicotinic agonist. Mol. Pharmacol. 45:1994;563-569.
5. Blagbrough I.S., Coates P.A., Hardick D.J., Lewis T., Rowan M.G., Wonnacott S., Potter B.V.L. Acylation of lycoctonine: semi-synthesis of inuline, delsemine analogues and methyllycaconitine. Tetrahedron Lett. 35:1994;8705-8708.
6. Boulter J., Connolly J., Deneris E., Goldman D., Heinemann S., Patrick J. Functional expression of 2 neuronal nicotinic acetylcholine-receptors from cDNA clones identifies a gene family. Proc. Nat. Acad. Sci. 84:1987;7763-7767.
7. Bruns R.F., Lawson-Wendling K., Pugsley T.A. A rapid filtration assay for soluble receptors using polyethylimine-treated filters. Anal. Biochem. 132:1983;74-81.
8. Chen D.-N., Patrick J.W. The α-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the α7 subunit. J. Biol. Chem. 272:1997;24024-24029.
9. Cheng Y.-C., Prussoff W.H. Relationship between the inhibition constant and the concentration of inhibitor which cause 50 percent of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
10. 3H]-α-bungarotoxin. J. Neurosci. 5:1985;1307-1315.
11. Clarke P.B.S. The fall and rise of neuronal α-bungarotoxin binding proteins. Trends Pharmacol. Sci. 13:1992;407-413.
12. Coates P.A., Blagbrough I.S., Hardick D.J., Rowan M.G., Wonnacott S., Potter B.V.L. Rapid and efficient isolation of the nicotinic receptor antagonist methyllycaconitine from delphinium - Assignment of the methylsuccinimide absolute stereochemistry as S. Tetrahedron Lett. 35:1994;8701-8704.
13. Coates P.A., Blagbrough I.S., Lewis T., Potter B.V.L., Rowan M.G. An HPLC assay for the norditerpenoid alkaloid methyllycaconitine, a potent nicotinic acetylcholine receptor antagonist. J. Pharm. Biomed. Anal. 13:1995;1541-1544.
14. Conroy W.G., Berg D.K. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem. 270:1995;4424-4431.
15. Cooper S.T., Millar N.S. Host cell-specific folding and assembly of the neuronal nicotinic acetylcholine receptor α7 subunit. J. Neurochem. 68:1997;2140-2151.
16. Couturier, S., Bertrand, D., Matter, J.-M., Hernandez, M.-C., Bertrand, S., Millar, N., Valera, S., Barkas, T., Ballivet, M., 1990. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron 5, 847-856.
17. Drasdo A., Caulfield M., Bertrand D., Bertrand S., Wonnacott S. Methyllycaconitine: a novel nicotinic antagonist. Mol. Cell Neurosci. 3:1992;237-243.
18. Duvoisin R.M., Deneris E.S., Patrick J., Heinemann S. The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit β4. Neuron. 3:1989;487-496.
19. Elgoyhen A.B, Johnson D.S., Boulter J., Vetter D.E., Heinemann S. α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 79:1994;705-715.
20. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of β4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 41:1992;31-37.
21. Forsayeth J.R., Kobrin E. Formation of oligomers containing the β3 and β4 subunits of the rat nicotinic receptor. J. Neurosci. 17:1997;1531-1538.
22. Garcha H.S., Thomas P., Spivak C.E., Wonnacott S., Stolerman I.P. Behavioral and ligand binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist. Psychopharmacology. 110:1993;347-354.
23. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain-I. J. Neurochem. 13:1966;655-669.
24. Gotti C., Hanke W., Schlue W.-R., Briscini L., Moretti M., Clementi F. A functional α-bungarotoxin receptor is present in chick cerebellum: purification and characterisation. Neuroscience. 50:1992;117-127.
25. Gotti C., Hanke W., Maury K., Moretti M., Ballivet M., Clementi F., Bertrand D. Pharmacology and biophysical properties of α7 and α7-α8 α-bungarotoxin receptor subtypes immunopurified from the chick optic lobe. Eur. J. Neurosci. 6:1994;1281-1291.
26. Guo J.-Z., Tredway T.L., Chiappinelli V.A. Glutamate and GABA release are enhanced by different subtypes of presynaptic nicotinic receptors in the lateral geniculate nucleus. J. Neurosci. 18:1998;1963-1969.
27. Hardick D.J., Cooper G., Scott-Ward T., Blagbrough I.S., Potter B.V.L., Wonnacott S. Conversion of the sodium channel activator aconitine into a potent α7-selective nicotinic ligand. FEBS Lett. 365:1995;79-82.
28. Hardick D.J., Blagbrough I.S., Cooper G., Potter B.V.L., Critchley T., Wonnacott S. Nudicauline and elatine as potent norditerpenoid ligands at the rat neuronal α-bungarotoxin binding sites: Importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding. J. Med. Chem. 39:1996a;4860-4866.
29. Hardick D.J., Blagbrough I.S., Potter B.V.L. Isotopic enrichment by asymmetric deuteriation. An investigation of the synthesis of deuteriated (S)-(-)-methylsuccinic acids from itaconic acid. J. Am. Chem. Soc. 118:1996b;5897-5903.
30. Keyser K.T., Britto L.R.G., Schoepfer R. et al. Three subtypes of α-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J. Neurosci. 13:1993;442-454.
31. Lindstrom J., Anand R., Peng X., Gerzanich V., Wang F., Li Y. Neuronal nicotinic receptor subtypes. Ann. NY Acad. Sci. 757:1995;100-116.
32. MacAllan D.R.E., Lunt G.G., Wonnacott S., Swanson K.L., Rapoport H., Albuquerque E.X. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett. 226:1988;357-363.
33. Marks M.J., Stitzel J.A., Romm E., Wehner J.M., Collins A.C. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine and αBgt. Mol. Pharmacol. 30:1986;427-436.
34. Markwell M.A.K., Hass S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:1978;206-210.
35. Nambi-Aiyar V., Benn M.H., Hanna T., Jacyno J., Roth S.H., Wilkins J.L The principle toxin of Delphinium brownii (Rydb.) and its mode of action. Experientia. 35:1979;1367-1368.
36. Palma E., Bertrand S., Binzoni T., Bertrand D. Neuronal α7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J. Physiol. 491:1996;151-161.
37. Quik, M., Choremis, J., Komourian, J., Lukas, R.J., Puchacz, E., 1996. Similarity between rat brain nicotinic α-bungarotoxin receptors and stably expressed α-bungarotoxin binding sites. J. Neurochem. 67, 145-154.
38. Ramirez-Latorre, J., Yu C.R., Qu X., Perin, F., Karlin, A., Role, L., 1996. Functional contributions of α5 subunit to neuronal acetylcholine receptor channels. Nature 380, 347-351.
39. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
40. Salvaterra P.M., Mahler H.R. Nicotinic acetylcholine receptor from rat brain: solubilization, partial purification and characterization. J. Biol. Chem. 251:1976;6327-6334.
41. Schechter N., Handy I.C., Pezzementi L., Schmidt J. Distribution of α-bungarotoxin binding sites in the central nervous system and peripheral organs of the rat. Toxicon. 16:1978;245-251.
42. Schoepfer R., Conroy W.G., Whiting P., Gore M., Lindstrom J. Brain α-bungarotoxin-binding protein cDNAs and mABs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron. 5:1990;35-48.
43. Segal M., Dudai Y., Amersterdam A. Distribution of an α-bungarotoxin-binding cholinergic nicotinic receptor in rat brain. Brain Res. 148:1978;105-119.
44. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:1993;596-604.
45. Tian L., Prior C., Dempster J., Marshall I.G. Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals. Br. J. Pharmacol. 122:1997;1025-1034.
46. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of human neuronal nicotinic receptor α5 subunits with β3, β2 and β4 subunits. J. Biol. Chem. 271:1996;17656-17665.
47. Ward J.M., Cockroft V.B., Lunt G.G., Smillie F.S., Wonnacott S. Methyllycaconitine: a selective probe for neuronal β-bungarotoxin binding site. FEBS Lett. 270:1990;45-48.
48. Whiteaker P., Sharples C.G.V., Wonnacott S. Agonist-induced upregulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol. Parmacol. 53:1998;950-962.
49. 4. FEBS Lett. 219:1987;459-463.
50. Wonnacott S. α-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain. J. Neurochem. 47:1986;1706-1712.
51. Wonnacott S., Harrison R., Lunt G.G. Interrelationship of carbohydrate and the α-toxin binding site on the acetylcholine receptor from Torpedo Marmorata. Life Sci. 27:1980;1769-1775.
52. Wonnacott S., Albuquerque E.X., Bertrand D. Methyllycaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses. Methods Neurosci. 12:1993;263-275.
53. Yu C., Role L.W. Functional contribution of the α7 subunit to multiple subtypes of nicotinic receptors in embryonic sympathetic neurons. J. Physiol Lond. 509:1998a;651-655.
54. Yu C., Role L.W. Functional contribution of the α5 subunit to neuronal nicotinic channels expressed by chick sympathetic ganglion neurons. J. Physiol. Lond. 509:1998b;667-681.
55. Yum L., Wolf K.M., Chipppinelli V.A. Nicotinic acetylcholine receptors in separate brain regions exhibit different affinities for methyllycaconitine. Neuroscience. 72:1996;545-555.